Basile Dalarun

Artiklar

Article: HELIYON. 2024;10(1):e23831
Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage
Mollick T; Darekar S; Dalarun B; Plastino F; Zhang J; Fernandez AP; Alkasalias T; Andre H; Lain S
Article: CELL DEATH DISCOVERY. 2022;8(1):464
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S
Journal article: EXPERIMENTAL NEUROLOGY. 2021;338:113606
Single- and two- chain tissue type plasminogen activator treatments differentially influence cerebral recovery after stroke
Anfray A; Brodin C; Drieu A; Potzeha F; Dalarun B; Agin V; Vivien D; Orset C

Corrigendum: CELL DEATH DISCOVERY. 2022;8(1):472
Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells (vol 15, pg 548, 2022)
Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S

Doktorand, Institutionen för mikrobiologi, tumör- och cellbiologi, Karolinska Institutet, 2021-
ST-Läkare, Barnmedicin, Barnkliniken, Linköping University Hospital, 2020-